News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lotus Tissue Repair Pioneers New Treatment for Rare and Disfiguring Disorder, Raises $26 Million From Third Rock


6/30/2011 8:02:10 AM

Lotus Tissue Repair Inc. has launched as a spinout from Third Rock Ventures, which led the Cambridge biotech’s $26 million Series A funding round. The funds will be used to develop the technology it licensed from the University of Southern California into a collagen-based therapy for a rare skin disorder. Philip Reilly, a partner at Third Rock, is one of the co-founders of the company and is serving as interim chief medical officer, according to the Lotus Tissue website. CEO Mark de Souza, formerly a vice president of business development with Dyax Corp., and CFO James Fordyce, managing partner of private advisory firm MEDNA Partners LLC, are the other co-founders of Lotus Tissue Repair.

Read at Mass High Tech
Read at Boston Globe
Read at Xconomy


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES